BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 20838174)

  • 1. Nursing role in the pharmaceutical life cycle.
    Becker J; Méndez-Quigley T; Phillips M
    Nurs Adm Q; 2010; 34(4):297-305. PubMed ID: 20838174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dosed without prescription: a framework for preventing pharmaceutical contamination of our nation's drinking water.
    Wu M; Janssen S
    Environ Sci Technol; 2011 Jan; 45(2):366-7. PubMed ID: 21175201
    [No Abstract]   [Full Text] [Related]  

  • 3. Invisible pollution: the impact of pharmaceuticals in the water supply.
    Strauch KA
    AAOHN J; 2011 Dec; 59(12):525-32; quiz 533. PubMed ID: 22132751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Climate change and human health: the role of nurses in confronting the issue.
    Sayre L; Rhazi N; Carpenter H; Hughes NL
    Nurs Adm Q; 2010; 34(4):334-42. PubMed ID: 20838179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hindsight rather than foresight: reality versus the EU draft guideline on pharmaceuticals in the environment.
    O'Brien E; Dietrich DR
    Trends Biotechnol; 2004 Jul; 22(7):326-30. PubMed ID: 15245903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Actor modelling and its contribution to the development of integrative strategies for management of pharmaceuticals in drinking water.
    Titz A; Döll P
    Soc Sci Med; 2009 Feb; 68(4):672-81. PubMed ID: 19110360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmaceuticals in on-site sewage effluent and ground water, Western Montana.
    Godfrey E; Woessner WW; Benotti MJ
    Ground Water; 2007; 45(3):263-71. PubMed ID: 17470115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Should renal nurses be aware of water quality?
    Chamney M; James R
    J Ren Care; 2008 Jun; 34(2):68-76. PubMed ID: 18498571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a common priority list of pharmaceuticals relevant for the water cycle.
    de Voogt P; Janex-Habibi ML; Sacher F; Puijker L; Mons M
    Water Sci Technol; 2009; 59(1):39-46. PubMed ID: 19151484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Occurrence and reductions of pharmaceuticals and personal care products and estrogens by municipal wastewater treatment plants in Ontario, Canada.
    Lishman L; Smyth SA; Sarafin K; Kleywegt S; Toito J; Peart T; Lee B; Servos M; Beland M; Seto P
    Sci Total Environ; 2006 Aug; 367(2-3):544-58. PubMed ID: 16697441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of carbamazepine in sewage treatment plant effluents and its implications for control strategies of pharmaceutical aquatic contamination.
    Zhang Y; Geissen SU
    Chemosphere; 2010 Sep; 80(11):1345-52. PubMed ID: 20594577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Newly Designed Water Treatment Systems for Hospital Effluent].
    Azuma T
    Yakugaku Zasshi; 2018; 138(3):289-296. PubMed ID: 29503418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disposal practices for unwanted residential medications in the United States.
    Glassmeyer ST; Hinchey EK; Boehme SE; Daughton CG; Ruhoy IS; Conerly O; Daniels RL; Lauer L; McCarthy M; Nettesheim TG; Sykes K; Thompson VG
    Environ Int; 2009 Apr; 35(3):566-72. PubMed ID: 19081631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transformation products of antibiotic and cytostatic drugs in the aquatic cycle that result from effluent treatment and abiotic/biotic reactions in the environment: an increasing challenge calling for higher emphasis on measures at the beginning of the pipe.
    Haddad T; Baginska E; Kümmerer K
    Water Res; 2015 Apr; 72():75-126. PubMed ID: 25600206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A pilot study for the assessment of pharmaceuticals as water contaminants].
    Bottoni P; Fidente R
    Ann Ist Super Sanita; 2005; 41(3):333-42. PubMed ID: 16552124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Are pharmaceuticals potent environmental pollutants? Part I: environmental risk assessments of selected active pharmaceutical ingredients.
    Carlsson C; Johansson AK; Alvan G; Bergman K; Kühler T
    Sci Total Environ; 2006 Jul; 364(1-3):67-87. PubMed ID: 16257037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic dose as the point of departure in assessing potential health hazards from drugs in drinking water and recycled municipal wastewater.
    Bull RJ; Crook J; Whittaker M; Cotruvo JA
    Regul Toxicol Pharmacol; 2011 Jun; 60(1):1-19. PubMed ID: 20056125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diffuse pollution of surface water by pharmaceutical products.
    Derksen JG; Rijs GB; Jongbloed RH
    Water Sci Technol; 2004; 49(3):213-21. PubMed ID: 15053118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discharge of pharmaceutical products (PPs) through a conventional biological sewage treatment plant: MECs vs PECs?
    Coetsier CM; Spinelli S; Lin L; Roig B; Touraud E
    Environ Int; 2009 Jul; 35(5):787-92. PubMed ID: 19201471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Molecules used for therapeutic or diagnostic purposes are micro water polluants].
    Levi Y
    Ann Pharm Fr; 2003 Nov; 61(6):365-72. PubMed ID: 14639186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.